University of California San Diego

BioCentury’s translational roundup also includes genetically distinct subtypes of autism linked to age of onset, and four papers from start-ups

BioCentury’s translational roundup also includes Roche’s PD-1 x IL-2 fusion, Charcot-Marie-Tooth investment, and three papers from start-ups

Also in BioCentury’s Clinical Report, updates from Akeso in three settings, and more

BioCentury’s translational roundup also includes Circle’s E2F-driven cancer therapy and table of obesity papers with links to companies

BioCentury’s translational roundup also identifies method to resensitize cells to KRAS inhibitors, a microglia transplant, and four papers from start-ups

BioCentury’s roundup of translational innovations also includes a KRAS G12V inhibitor, an AMD beneficial gene variant, and newcos in the literature

BioCentury’s roundup of translational innovations also includes a protein conjugation strategy, a SMURF1 inhibitor for hypertension, and more

Recently published studies reveal advances in precision and performance, driven largely by labs in China

BioCentury’s roundup of translational innovation features two trios of papers: one on genetic control of cancer and the other on MASLD markers